<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>MIKROBLARGA QARSHI KIMYOTERAPIYA MUAMMOLARI: KLINIK  AMALIYOTDA BAKTERIYALARNING REZISTENTLIK MEXANIZMLARI  VA ULARNI BARTARAF ETISH YOʻLLARI</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Kibriyeva</mods:namePart><mods:namePart type="family">Maxfirat</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Abdumurotova</mods:namePart><mods:namePart type="family">Jasmina</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu maqolada mikroblarga qarshi kimyoterapiya (antibiotiklar)nbsp;samarasini pasaytiruvchi eng dolzarb muammolardan biri — bakteriyalarning dorinbsp;vositalariga chidamliligi (rezistentligi) masalalariga bagʻishlangan. Ishdanbsp;bakteriyalarning antimikrob preparatlarni parchalash (fermentativ inaktivatsiya), dorinbsp;nishonlarini oʻzgartirish, hujayra membranasi oʻtkazuvchanligini pasaytirish va dorinbsp;moddasini hujayradan tashqariga haydash (efflyuks nasoslari) kabi molekulyar vanbsp;genetik mexanizmlari atroflicha tahlil qilingan. Shuningdek, mazkur muammoninbsp;bartaraf etish yoʻllari — ratsional antibiotikoterapiya tamoyillariga amal qilish,nbsp;kombinatsiyalangan davolash usullarini qoʻllash hamda zamonaviy farmakologiyadanbsp;ishlab chiqilayotgan yangi avlod preparatlari va ferment ingibitorlaridan foydalanishnbsp;strategiyalari yoritilgan.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-07</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>